Background & Aims Fibrosis is a common complication of inflammatory bowel diseases
(IBDs). The pregnane X receptor (PXR)(encoded by NR1I2) suppresses intestinal …

It has been more than 25 years since Mycobacterium paratuberculosis was first proposed as
an etiologic agent in Crohn's disease based on the isolation of this organism from several …

Inflammatory bowel disease (IBD), historically subdivided into Crohn's disease and
ulcerative colitis, is a very heterogeneous condition. While the tendency in medicine is to try …

Abstract Background and Aim Escherichia coli pathobionts and particularly the adherent
invasive E. coli (AIEC) may play a putative role in initiating and maintaining the inflammatory …

Epidemiology, Natural History, and Risk Stratification of Crohn's Disease - Gastroenterology
Clinics Skip to Main Content Advertisement Gastroenterology Clinics Log in Register Log in …

Inflammatory bowel diseases (IBD) are chronic and disabling conditions. Accumulating
evidence indicates that we need to look beyond clinical symptoms as current therapeutic …

Over the past decades, there has been a rapid increase in the incidence and prevalence of
inflammatory bowel disease (IBD) in Asia. The natural history of IBD in Asian patients could …

Background Fibrotic strictures in patients with inflammatory bowel disease (IBD) are often
not amenable to medical therapy. Therapy with endoscopic balloon dilation usually requires …

Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal inflammatory disorder
with unidentified causes. Both environmental factors and genetic aspects are believed to be …

The management of inflammatory bowel disease [IBD] is complex, and requires tight control
of disease activity, close monitoring to avoid treatment side effects, health care professionals …